Local recurrence in breast carcinoma patients with T1-2 and 1-3 positive nodes: Indications for radiotherapy

European Journal of Surgical Oncology

Volumn 33, Issue 1, 2007, Pages 28-32

  Yildirim, E ^a   Berberoglu, U ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

1 3 positive nodes; Breast carcinoma; Prognosis; Radiotherapy; Ratio

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOSPORIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT INDICATION; UNIVARIATE ANALYSIS;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33846354271     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.10.022     Document Type: Article

References (25)

1. Arriagada R., Rutqvist L.E., Mattsson A., Kramar A., and Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 13 (1995) 2869-2878
2. Olivotto I.A., Truong P.T., and Chua B. Postmastectomy radiation therapy: who needs it?. J Clin Oncol 22 (2004) 4237-4239
3. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
5. Truong P.T., Berthelet E., Lee J., Kader H.A., and Olivotto I.A. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 103 (2005) 2006-2014
6. Katz A., Buchholz T.A., Thames H., et al. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys 50 (2001) 397-403
7. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC cancer staging manual (2002), Springer-Verlag, New York, NY
8. Kaplan E.L., and Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 53 (1958) 457-481
9. Cox D.R. Regression models and life tables. J R Stat Soc B34 (1972) 187-220
10. Kleinbaum D.G. Survival analysis (1996), Springer, New York p. 211-54
11. Fernando I.N. The role of radiotherapy in patients undergoing mastectomy for carcinoma of the breast. Clin Oncol 12 (2000) 158-165
12. van Tienhoven G., Voogd A.C., Peterse J.L., et al. Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). Eur J Cancer 35 (1999) 32-38
13. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
14. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med 337 (1997) 949-955
15. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group 82c randomised trial. Lancet 353 (1999) 1641-1648
16. Taghian A., Jeong J.H., Mamounas E., et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy. Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22 (2004) 4247-4254
17. Whelan T., and Levine M. More evidence that locoregional radiation therapy improves survival: what should we do?. J Natl Cancer Inst 97 (2005) 82-84
18. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
19. Jager J.J., Volovics L., Schouten L.J., et al. Locoregional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol 50 (1999) 267-275
20. Fodor J., Poglar C., Major T., and Nemeth G. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation. Strahlenther Onkol 179 (2003) 197-202
21. Cheng J.C.H., Chen C.M., Liu M.C., et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 980-988
22. Voordeckers M., Vinh-Hung V., Van de Steen J., Lamote J., and Storme G. The lymph node ratio as prognostic factor in node positive breast cancer. Radiother Oncol 70 (2004) 225-230
23. Vin-Hung V., Verschraegen C., Promish D.I., et al. Ratios of involved nodes in breast cancer. Breast Cancer Res 6 (2004) R680-R688
24. Recht A., Gray R., Davidson N.E., et al. Locoregional failure ten years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 1689-1700
25. Wallgren A., Bonetti M., Gelber R.D., et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group trials I through VII. J Clin Oncol 21 (2003) 1205-1213